;
RCT
Published: May 2016
ACE Report #9045
Ace Report Cover Metabolic Disorders

Efficacy of combined teriparatide & denosumab vs. single-drug treatment for osteoporosis


Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)

J Clin Endocrinol Metab. 2016 May;101(5):2023-30

Contributing Authors: JN Tsai AV Uihlein H Lee RM Neer BZ Leder ML Bouxsein SM Burnett-Bowie NP Derrico

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.